Is the coronavirus on its way out?
You might think so. New, updated booster shots are being rolled out to better protect against the variants circulating now. The U.S. Centers for Disease Control and Prevention has dropped COVID-19 quarantine and distancing recommendations. And more people have thrown off their masks and returned to pre-pandemic activities.
But scientists say no. They predict the scourge that’s already lasted longer than the 1918 flu pandemic will linger far into the future.
One reason it’s lasted this long? It’s gotten better and better at getting around immunity from vaccination and past infection. Scientists point to emerging research that suggests the latest omicron variant gaining ground in the U.S. — BA.4.6, which was responsible for around 8% of new U.S. infections last week — appears to be even better at evading the immune system than the dominant BA.5.
Scientists worry the virus may well keep evolving in worrisome ways.
How long will it be around?
White House COVID-19 coordinator Dr. Ashish Jha said COVID-19 will likely be with us for the rest of our lives.
Experts expect COVID-19 will someday become endemic, meaning it occurs regularly in certain areas according to established patterns. But they don’t think that will be very soon.
Still, living with COVID “should not necessarily be a scary or bad concept,” since people are getting better at fighting it, Jha said during a recent question-and-answer session with U.S. Sen. Bernie Sanders of Vermont. “Obviously if we take our foot off the gas — if we stop updating our vaccines, we stop getting new treatments — then we could slip backwards.”
Experts say COVID will keep causing serious illness in some people. The COVID-19 Scenario Modeling Hub made some pandemic projections spanning August 2022 to May 2023, assuming the new tweaked boosters adding protection for the newest omicron relatives would be available and a booster campaign would take place in fall and winter. In the most pessimistic scenario — a new variant and late boosters — they projected 1.3 million hospitalizations and 181,000 deaths during that period. In the most optimistic scenario — no new variant and early boosters — they projected a little more than half the number of hospitalizations and 111,000 deaths.
Eric Topol, head of Scripps Research Translational Institute, said the world is likely to keep seeing repetitive surges until “we do the things we have to do,” such as developing next generation vaccines and rolling them out equitably.
Topol said the virus “just has too many ways to work around our current strategies, and it’ll just keep finding people, finding them again, and self-perpetuating.”
How will the virus mutate?
Scientists expect more genetic changes that affect parts of the spike protein studding the surface of the virus, letting it attach to human cells.
But the virus probably won’t keep getting more transmissible forever.
“I think there is a limit,” said Matthew Binnicker, director of clinical virology at Mayo Clinic in Rochester, Minnesota. “What we’re really dealing with, though, is there’s still a lot of people across the world who don’t have any prior immunity — either they haven’t been infected or they haven’t had access to vaccination.”
If humanity’s baseline level of immunity rises significantly, he said, the rate of infections, and with that emergence of more contagious variants, should slow down.
But there is a chance the virus could mutate in a way that causes more severe illness.
“There’s not any inherent reason, biologically, that the virus has to become milder over time,” said Dr. Wesley Long, a pathologist at Houston Methodist. The fact it may seem milder now “is likely just the combined effect of all of us having some immune history with the virus.”
While scientists hope that continues, they also point out that immunity gradually wanes.
Will the next variant be another version of Omnicron?
Omicron has been around since late last year, with a series of super transmissible versions quickly displacing one another, and Binnicker believes “that will continue at least for the next few months.”
But down the road, he said it’s likely a new variant distinct from omicron will pop up.
The recent wave of infections and re-infections, he said, “gives the virus more chances to spread and mutate and new variants to emerge.”
Can people influence the future of the virus?
Yes, experts said. One way is to get vaccinated and boosted.
“We have a virus out there that’s still circulating, still killing hundreds of Americans every day,” Jha said in a press briefing Tuesday. But, he added: “We now have all of the capability to prevent, I believe, essentially all of those deaths. If people stay up to date on their vaccines, if people get treated if they have a breakthrough infection, we can make deaths from this virus vanishingly rare.”
Not only does vaccination protect against severe disease and death, it raises the level of immunity globally.
CDC director Rochelle Walensky said Tuesday that up to 100,000 COVID-19 hospitalizations and 9,000 deaths could be prevented if Americans get the updated booster at the same rate they typically get an annual flu shot this fall. About half of Americans are typically vaccinated against the flu each year.
People can also keep protecting themselves by taking other precautions like, for example, wearing masks indoors when COVID rates are high.
Longtime nurse Catherine Mirabile said it’s important not to dismiss the dangers of the coronavirus — which sickened her twice, nearly killed her husband and left them both with long COVID. Daily deaths still average around 450 in the U.S.
“People really need to look at this and still take this seriously,” said the 62-year-old from Princeton, West Virginia, who is now on disability. “They could end up in the same shape we’re in.”

News
Scientists Use Exotic DNA To Help Create “Climate-Proof” Crops
The incorporation of exotic DNA from wild relatives into wheat results in a remarkable yield increase of up to 50%, even in hot weather, surpassing elite lines without these genes. Amid a year of [...]
Australia becomes first country to recognise psychedelics as medicines
Australia has become the first country to recognise psychedelics as medicines, after the Therapeutic Goods Administration took researchers by surprise and approved the psychedelic substances in magic mushrooms and MDMA for use by people [...]
Silver nanoparticles show promise in fighting antibiotic-resistant bacteria
In a new study, scientists with the University of Florida have found that a combination of silver nanoparticles and antibiotics is effective against antibiotic-resistant bacteria. The researchers hope to turn this discovery into viable [...]
Combating severe cancer with a new drug delivery system
Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with [...]
New Research Shows How Ketamine Acts As “Switch” in the Brain
According to a new study by researchers at Penn Medicine, ketamine, which is well-known as an anesthetic and is becoming increasingly popular as an antidepressant, dramatically reorganizes activity in the brain, almost as if [...]
Supercharged T Cells: A New Way To Kill Pancreatic Cancer With Minimal Side Effects
A new immunotherapy releases cancer-killing cytokines only within the tumor. Researchers at the University of California San Francisco (UCSF) have developed a new T cell-based immunotherapy that selectively targets cancer cells, producing a powerful anti-cancer cytokine [...]
AI has designed bacteria-killing proteins from scratch – and they work
An AI was tasked with creating proteins with anti-microbial properties. Researchers then created a subset of the proteins and found some did the job. An AI has designed anti-microbial proteins that were then tested [...]
Using nanoparticles, researchers can identify and deliver synergistic combinations of cancer drugs
Treating cancer with combinations of drugs can be more effective than using a single drug. However, figuring out the optimal combination of drugs, and making sure that all of the drugs reach the right [...]
Humanity May Reach Singularity Within Just 7 Years, Trend Shows
By one unique metric, we could approach technological singularity by the end of this decade, if not sooner. A translation company developed a metric, Time to Edit (TTE), to calculate the time it takes for professional [...]
HYPER (Highly Interactive Particle Relics) – A New Model for Dark Matter
Phase transition in early universe changes strength of interaction between dark and normal matter. Dark matter remains one of the greatest mysteries of modern physics. It is clear that it must exist, because without [...]
New Nanoparticles Deliver Therapy Brain-Wide and Edit Alzheimer’s Gene
Summary: Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of [...]
Cancer’s Secret Weapon? Enzyme That Protects Against Viruses May Fuel Tumor Evolution
An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The [...]
Scientists Uncover Japanese Fruit Juice That May Help Prevent Lung Cancer
Using a mouse model, Japanese researchers unleash the likely mechanism of action of Actinidia arguta (sarunashi) juice on lung cancer development. Lung cancer is a leading cause of death in Japan and across the [...]
In-place manufacturing method improves gas sensor capabilities, production time
When used as wearable medical devices, stretchy, flexible gas sensors can identify health conditions or issues by detecting oxygen or carbon dioxide levels in the breath or sweat. They also are useful for monitoring [...]
In the core of the cell: New insights into the utilization of nanotechnology-based drugs
Novel drugs, such as vaccines against covid-19, among others, are based on drug transport using nanoparticles. Whether this drug transport is negatively influenced by an accumulation of blood proteins on the nanoparticle’s surface was [...]
The costly lesson from COVID: why elimination should be the default global strategy for future pandemics
Imagine it is 2030. Doctors in a regional hospital in country X note an expanding cluster of individuals with severe respiratory disease. Rapid whole-genome sequencing identifies the disease-causing agent as a novel coronavirus. Epidemiological [...]